Health Care: Drugs

Orexigen Therapeutics Inc (OREX: NASDAQ)

$7.95 0.2 | 2.58%
03/31/15 - 02:27 PM ET
Company Income Statement
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Sales 55.52M 3.43M 3.43M 4.40M
Cost of Sales 0.00 0.00 0.00 0.00
Gross Operating Profit 55.52M 3.43M 3.43M 4.40M
Selling, General, and Administrative Expenses 28.64M 23.88M 19.99M 19.50M
Research & Development 57.41M 56.75M 73.68M 12.78M
Operating Income before D & A (EBITDA) -30.53M -77.20M -90.24M -27.88M
Depreciation & Amortization 4.81M 1.22M 813.00K 1.50M
Interest Income 88.00K 65.00K 147.00K 46.00K
Other Income - Net 0.00 0.00 0.00 0.00
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -35.25M -78.36M -90.90M -29.34M
Interest Expense 7.08M 538.00K 2.00K 221.00K
Pre-Tax Income -42.34M -78.90M -90.91M -29.56M
Income Taxes 0.00 0.00 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -37.52M -77.67M -90.09M -28.06M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -37.52M -77.67M -90.09M -28.06M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -37.52M -77.67M -90.09M -28.06M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-37.52M -77.67M -90.09M -28.06M
Preferred Dividends
Net Income Available To Common -37.52M -77.67M -90.09M -28.06M
Basic EPS from Continuing Ops. -0.32 -0.80 -1.27 -0.58
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -0.32 -0.80 -1.27 -0.58
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.32 -0.80 -1.27 -0.58
Basic Normalized Net Income/Share -0.32 -0.80 -1.27 -0.58
EPS fr Continuing Ops. -0.32 -0.80 -1.27 -0.58
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -0.32 -0.80 -1.27 -0.58
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.32 -0.80 -1.27 -0.58
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.32 -0.80 -1.27 -0.58
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with OREX

Latest OREX Headlines from TheStreet

More Financial News for OREX

Press Releases for OREX

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter